Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this prospective longitudinal cohort the investigators reported the clinical, and biological characteristics of all critically ill patients admitted in the pediatric intensive care unit (PICU) of Bicêtre Hospital during the 2019 coronavirus disease (COVID-19) pandemics. Patients were older than 37 weeks of gestational age. No upper limit was set as the unit was transiently converted into a pediatric "adult COVID-19" intensive care unit.
All patients will be monitored during their PICU stay.
Clinical characteristics include: age, gender, co-morbidities, organ support therapies (mechanical ventilation, renal replacement therapy, extracorporeal membrane oxygenation, vasopressors), organ complications (pulmonary embolism, acute respiratory distress syndrome, renal failure, heart failure) and function, infective complications (ventilator associated pneumonia, central line associated bloodstream infection, pulmonary access, sepsis, septic shock), microbiologic and viral identification, 7-day and 28-day mortality.
Biological characteristics include:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pediatric patients | All term children from birth to 18 years of age admitted in the PICU | ||
| Adult patients | All patients >18 years of age |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of patient with secondary infection | Secondary infection will include healthcare associated infections as well as sepsis, and septic shock | 2 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients dying | mortality | 7-day, 28-day and 60-day |
| Description of clinical phenotypes | Description of the variable clinical phenotypes of COVID-19 in adults and children. This include COVID-19 respiratory failure, acute myocarditis and multi system inflammatory syndrome in children (MIS-C) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Most patients admitted in the PICU of Bicêtre Hospital are children <18 years old. Adults critically ill patients with COVID-19 were admitted in case of patients overflow in adult Intensive Care Unit.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Pierre Tissieres, MD, DSc | Contact | +33145213205 | pierre.tissieres@aphp.fr | |
| Clemence Marais, MD, MSc | Contact | +33145213205 | clemence.marais@aphp.fr |
| Name | Affiliation | Role |
|---|---|---|
| Pierre Tissieres, MD, DSc | Bicêtre Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pediatric Intensive Care and Neonatal Medicine, Bicêtre Hospital, AP-HP PAris Saclay University | Recruiting | Le Kremlin-Bicêtre | 94275 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| D007239 | Infections |
| D016638 | Critical Illness |
| D045169 | Severe Acute Respiratory Syndrome |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D014777 | Virus Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| through study completion, an average of 4 weeks |
| Description of immunological phenotypes | Measure circulating cell phenotypes (relative percentage and monocyte classII histocompatibility complex | through study completion, an average of 4 weeks |
| D018352 |
| Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D007945 | Leukemia, Lymphoid |
| D007938 | Leukemia |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D008232 | Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |